Some Thoughts on Sociedad Quimica y Minera

Shares of Sociedad Quimica y Minera have moved -2.1% today, and are now trading at a price of $80.19. In contrast, the S&P 500 index saw a 0.4% change. Today's trading volume is 914,860 compared to the stock's average volume of 1,699,696.

Sociedad Química y Minera de Chile S.A. produces and distributes specialty plant nutrients, iodine and its derivatives, lithium and its derivatives, potassium chloride and sulfate, industrial chemicals, and other products and services. Based in Santiago de Chile, Chile the company has 6,776 full time employees and a market cap of $22,905,313,280. Sociedad Quimica y Minera currently offers its equity investors a dividend that yields 5.8% per year.

The company is now trading -28.45% away from its average analyst target price of $112.08 per share. The 16 analysts following the stock have set target prices ranging from $80 to $145, and on average give Sociedad Quimica y Minera a rating of hold.

Over the last year, SQM shares have gone up 57.9%, which represents a difference of 75.3% when compared to the S&P 500. The stock's 52 week high is $115.76 per share whereas its 52 week low is $49.15. Based on Sociedad Quimica y Minera's average gross margins growth of 17.8% over the last four years, its core business remains strong and the stock price may maintain this level of performance.

Date Reported Revenue ($ MM) Cost of Revenue ($ MM) Gross Margins (%) YoY Growth (%)
2021-12-31 2,862 1,772 38.08 43.32
2020-12-31 1,817 1,334 26.57 -7.78
2019-12-31 1,944 1,384 28.81 n/a
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.